STAT
JANUARY 25, 2024
A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13. Many previous studies have shown that HPV vaccines are extremely effective in preventing cervical cancer.
PharmaVoice
JANUARY 25, 2024
The publicly announced procedure has highlighted one of the most prevalent and deadly cancers among men, and the treatments being developed to combat it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 25, 2024
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney. Sanders, who has threatened to subpoena the CEOs of Merck and Johnson & Johnson over their refusal to testify at a hearing on why drug prices are higher in the United States than other countries, told reporters the reasons the companies gave ranged fro
The Pharmacist
JANUARY 25, 2024
Community pharmacies that have ordered but not yet received an otoscope may begin offering the Pharmacy First service from 31 January without the otitis media clinical pathway. This comes in response to reports of pharmacy owners struggling to get hold of otoscopes, The Pharmacist understands. NHS England (NHSE) made the concession in a letter to pharmacy contractors […] The post Pharmacies can start Pharmacy First without an otoscope, says NHSE appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 25, 2024
Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high rates of HIV. Yet so far, no standardized surveillance system has collected data that could provide insight into the factors that put people at higher risk for contracting the virus. A survey of transgender women, developed by the Centers for Disease Control and Prevention, aimed to gather and assess behavioral data in relation to HIV prevention and risk for the first time.
PharmaVoice
JANUARY 25, 2024
Key trends on the horizon in the life sciences this year.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
JANUARY 25, 2024
Understanding the responsibilities of a pharmacist employed under the Additional Roles Reimbursement Scheme and ensuring those in post are supported at work have been cited as recent challenges within primary care networks (PCNs) and practices. Here, Krupa Dave and Devinder Kalsi, lead medicines optimisation pharmacists at Central London Community Healthcare Trust (CLCH), share the structured workplan […] The post How PCNs can support pharmacists: guidance from a London trust appeared firs
STAT
JANUARY 25, 2024
LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and one in South Africa — have teamed up on a partnership that they say will expand their efforts to track emerging disease threats around the world. The collaboration between the U.K.’s Wellcome Sanger Institute and South Africa’s Centre for Epidemic Response and Innovation, announced Thursday, comes as much of the infrastruc
pharmaphorum
JANUARY 25, 2024
Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
STAT
JANUARY 25, 2024
Senate Majority Leader Chuck Schumer (D-N.Y.) wants the federal government to investigate Zyn nicotine pouches. Schumer is no stranger to calling for crackdowns on popular products — he’s done similar with Four Loko and Logan Paul’s line of energy drinks. The problem for Schumer this time around is that many users of Zyn are very passionate, and very, very online.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Guardian - Pharmaceutical Industry
JANUARY 25, 2024
Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’ The EU is to stockpile key medicines that will worsen the record drug shortages in the UK, with experts warning that the country could be left “behind in the queue”. The EU is seeking to safeguard its supplies by switching to a system in which its 27 members work together to secure reliable supplies of 200 commonly used medications, such as antibiotics, painkillers and vaccines.
STAT
JANUARY 25, 2024
CVS Health is perhaps best known for two things. First, there are the comically long receipts that have inspired hundreds of internet memes. And then there’s the ubiquitous presence of its stores. If it seems like there’s a CVS pharmacy on every other block, that’s because the company operates 9,000 stores nationwide, including nearly 500 across Massachusetts.
pharmaphorum
JANUARY 25, 2024
On today’s podcast, host Jonah Comstock is joined by Arturo Araya, EVP of commercialisation at Cellares, a company that is attempting to create a new kind of contract manufacturing organisation for the rapidly crystalizing world of cell and gene therapy.
STAT
JANUARY 25, 2024
Humana’s Medicare Advantage business is faring even worse than the company let on last week , with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment. The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected.
Pharmaceutical Business Review
JANUARY 25, 2024
The facility is designed to bolster in-house production of drug substances for Investigational New Drug (IND)-enabling studies and trials. This development is pivotal for the company’s proprietary and partnered programme pipelines. The 20,000ft 2 facility includes a lipid formulation production suite and additional suites for mRNA and plasmid DNA (pDNA) manufacturing.
STAT
JANUARY 25, 2024
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word. The organization, called Maisha Meds, plays the role of a middleman between international groups like USAID and the Gates Foundation and pharmacies. By definition, it’s a PBM. But since it’s a nonprofit company and it subsidizes medicines and tests aimed at promoting public health, it’s hesitant to describe itself t
Pharma Times
JANUARY 25, 2024
Around 50% of babies born with the condition are affected by heart defects
STAT
JANUARY 25, 2024
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to administer drugs in outpatient settings. After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions for the problems.
Digital Pharmacist
JANUARY 25, 2024
Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: In the digital age, online visibility is crucial for businesses to thrive. For pharmacy owners, establishing a strong online presence can significantly impact their success.
STAT
JANUARY 25, 2024
Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists. Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself.
Express Pharma
JANUARY 25, 2024
STEER World announced the appointment of TN Hari as its Executive Chairman. Hari will set the strategic direction for STEER’s Engineering, Life Sciences and Materials businesses and oversee its implementation. He will also provide guidance and support to the CEOs of STEER’s various businesses and the Corporate Services Group. A press statement from the company informed, “Hari is a distinguished professional with a multifaceted career, serving as an Angel Investor, Advisor to Venture Capitalists,
STAT
JANUARY 25, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with the plight of the venture capitalist, an idea for Gilead Sciences, and the latest in the quest to find potent treatments for Parkinson’s disease.
European Pharmaceutical Review
JANUARY 25, 2024
Eli Lilly and Company’s Executive Vice President of Global Quality, Johna Norton, is ending her lengthy tenure with the company this summer and retiring after 34 years of service. However, she will continue in her current role and remain as part of Eli Lilly’s Executive Committee of until 31 July 2024. “Johna’s career has been built on her commitment to ensuring that our medicines are produced with the highest quality standards.
STAT
JANUARY 25, 2024
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Bernie’s subpoena showdown We’re less than a week away from a scheduled vote on subpoenaing the CEOs of two drugmakers, J&J and Merck.
pharmaphorum
JANUARY 25, 2024
UK government is reported to be considering financial aid for AstraZeneca to seal a deal to expand a vaccines manufacturing facility in Speke
STAT
JANUARY 25, 2024
The trade group for generic drug companies in the U.S. has filed a lawsuit alleging a new Illinois law that is designed to prevent price gouging is unconstitutional, the latest effort to push back against states attempting to lower the cost of medicines. In its lawsuit, the Association for Accessible Medicines argued the law gives the state the power to regulate interstate commerce.
pharmaphorum
JANUARY 25, 2024
NICE firms up guidance backing NHS use of five digital health wearables for remote monitoring of Parkinson's disease patients
STAT
JANUARY 25, 2024
Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale. Gilead needs Arcellx more than ever The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business.
Express Pharma
JANUARY 25, 2024
The Association for Advancement in Pharmaceutical Sciences (AAiPS) has appointed Dr Ramaswamy Lakshmanan as the AAiPS India Ambassador. Dr Lakshmanan is a pharma professional with nearly 45 years of experience. He is currently serving as the Managing Director of Sotax India since October 2010, a subsidiary of Sotax AG, Switzerland. He has many achievements to his credit.
STAT
JANUARY 25, 2024
Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding.
Outsourcing Pharma
JANUARY 25, 2024
Meghan Harrington recently joined Medidata as vice president of product, clinical trial financial management and is responsible for driving the strategic direction of the grants manager and payments products.
STAT
JANUARY 25, 2024
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny, nonetheless. Why? We recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.
European Pharmaceutical Review
JANUARY 25, 2024
Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. These standardised documents provide meticulously curated and scientifically approved information. They detail the medication’s intended use, proper administration, potential side effects and precautions. They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe.
The Pharmacist
JANUARY 25, 2024
Pharmacy First will launch on 31 January, with the required IT updates in place, NHS England (NHSE) confirmed today. And the process of integrating with general practice records will be further rolled out during February 2024. More than 10,000 pharmacies have registered to deliver Pharmacy First to date, NHSE said in a letter to community […] The post Pharmacy First will launch as planned on 31 January, NHSE confirms appeared first on The Pharmacist.
Express Pharma
JANUARY 25, 2024
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Gabapentin Tablets (Once-Daily), 300 mg and 600 mg (USRLD: Gralise Tablets). Zydus is the first company to receive final approval for generic Gabapentin Tablets (Once-Daily), 300 mg and 600 mg. Following approval, the product will be launched immediately in the US.
Expert insights. Personalized for you.
364 
Let's personalize your content